Review identifies factors behind physicians’ reluctance to use addiction treatments

FHS
July 30, 2024
6:51 pm

Despite the high prevalence of addiction and substance use disorders in the United States, the number of physicians adopting evidence-based substance use disorder interventions in their clinical practice remains low.

Realising the opportunities for growth in the European orphan drug market – Pharmaceutical Technology

The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union (EU) counts 36

March 6, 2025

Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 24, 2024

Does long-term, daily low-dose aspirin treatment affect the incidence of stroke or intracerebral bleeding?

Researchers found that older adults who took aspirin had a 38% higher risk of intracranial bleeding.

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.